Synthetic Biology Industry Overview
The global synthetic biology market was valued at USD 16.22 billion in 2024 and is projected to experience significant growth, with a compound annual growth rate (CAGR) of 17.30% from 2025 to 2030. This growth can be attributed to the emergence of various applications of synthetic biology, particularly in areas such as multiplexed diagnostics, cellular recording, and therapeutic genome editing. As these applications gain traction, they are expected to drive a substantial increase in the demand for synthetic products throughout the forecast period. Moreover, the integration of synthetic biology techniques and products into sectors such as energy and chemicals is anticipated to further enhance overall market growth. As the applications of synthetic biology continue to diversify, its utility is likely to expand, leading to broader adoption and accelerated market development.
The impact of the COVID-19 pandemic has notably amplified the utilization of synthetic biology products over the past two years. In response to the crisis, numerous leading pharmaceutical and biotechnology companies, as well as prominent players in the synthetic biology field, have intensified their research efforts on a global scale. These organizations have employed innovative techniques to produce critical tools such as test kits, therapies, and vaccines for COVID-19. A study by the European Parliament highlights synthetic biology as a developing technology with significant potential applications for addressing COVID-19 infections. Additionally, the U.S. National Institutes of Health has recognized synthetic biology as a crucial tool for expediting vaccine development, underscoring its importance in public health initiatives. This heightened focus on synthetic biology during the pandemic is likely to influence its growth trajectory and expand its applications in the future.
Gather more insights about the market drivers, restrains and growth of the Synthetic Biology Market
Regional Insights:
North America synthetic biology market held the largest market share of 41.98% in 2024, driven by strong investment from both public and private sectors, including significant funding from venture capital and government initiatives. The region's robust research infrastructure, with leading universities and research institutions, accelerates technological advancements. In addition, a growing demand for sustainable solutions in agriculture, healthcare, and energy encourages the development of synthetic biology applications.
U.S. Synthetic Biology Market Trends
The U.S. synthetic biology market is expected to expand in the near future due to the presence of key market players in this country. Furthermore, the presence of leading universities and research institutions fosters innovation and collaboration. A robust regulatory environment encourages biotechnological advancements while addressing safety and ethical concerns. The growing interest in personalized medicine and bio-based products reflects changing consumer preferences, which can contribute to the market growth in the U.S.
Europe Synthetic Biology Market Trends
The Europe synthetic biology market is experiencing significant growth. Strong public funding and investment from the European Union promote research and innovation. A focus on sustainability and environmental regulations encourages the development of eco-friendly solutions across industries, particularly in agriculture and energy. Europe's well-established academic institutions facilitate collaboration and knowledge sharing. The region's diverse regulatory landscape fosters innovation while ensuring safety, and strategic partnerships among academia, industry, and startups create a vibrant ecosystem for market growth.
The UK synthetic biology market held a significant share in 2024. Strong government support, including funding initiatives like the Biotechnology and Biological Sciences Research Council (BBSRC), is fueling the market. Furthermore, growing scientific awareness and interest in bio-based products in the country is expected to boost the market over the forecast period.
France synthetic biology market is expected to grow remarkably over the forecast period. The French government encourages research and innovation in life sciences through funding initiatives, tax breaks, and infrastructure improvements. This backing boosts investments in areas like biotechnology, genomics, and personalized medicine, leading to a heightened interest in synthetic biology within these sectors.
The synthetic biology market in Germany is anticipated to grow significantly over the forecast period. The nation has significant investments in biotechnology and a solid research infrastructure. Its emphasis on creating innovative therapies, combined with ample public and private funding, is fuelling the demand for synthetic biology products across various biomedical applications.
Asia Pacific Synthetic Biology Market Trends
The Asia Pacific synthetic biology market is projected to grow at the fastest CAGR of 18.91% over the forecast period. Countries in the Asia Pacific region, including India, China, South Korea, and Japan, are witnessing significant industrialization and economic growth, driving demand across various sectors, particularly in pharmaceuticals and biotechnology, both of which increasingly utilize synthetic biology. Major investments from governments and private companies in healthcare infrastructure, pharmaceutical research, and life sciences are boosting the need for synthetic biology solutions.
The synthetic biology market in China is expected to grow over the forecast period. The Chinese government is actively fostering the expansion of its domestic pharmaceutical industry, which includes significant developments in synthetic biology. These initiatives are leading to increased funding for research and development, positively impacting the market as a whole. Furthermore, China's aging population is driving a higher demand for treatments for chronic diseases, creating a greater reliance on innovative solutions. This rising need for effective therapies is expected to significantly enhance the growth of the market as companies focus on developing advanced approaches to meet these healthcare challenges.
Japan synthetic biology market is witnessing significant growth over the forecast period. The market in Japan is experiencing rapid growth, fueled by a rising demand for gene therapies and innovative treatments. Major companies are investing in cutting-edge technologies and facilities to improve production efficiency and scalability. These advancements are establishing Japan as a key center for synthetic biology innovation and the development of biopharmaceuticals.
MEA Synthetic Biology Market Trends
The MEA synthetic biology market is projected to grow significantly over the forecast period. This expansion is driven by advancements in gene therapy and an increasing emphasis on addressing rare diseases. Enhanced funding from both public and private sectors, along with collaborative research initiatives, is creating a robust ecosystem for innovation. As regulatory frameworks continue to evolve, the region is expected to see a rise in companies offering cutting-edge biomanufacturing solutions.
Saudi Arabia synthetic biology market is set to expand in line with Vision 2030, which prioritizes biotechnology as a key sector. Significant investments in research facilities and partnerships with international companies are strengthening local capabilities. In addition, the country's strategic location provides access to emerging markets in the region, further enhancing its manufacturing potential.
The synthetic biology market in Kuwait is also anticipated to grow, driven by increased investments in biotechnology and gene therapy research. Government initiatives aimed at promoting advanced medical technologies, along with collaborations with international research institutions, are bolstering local capabilities and positioning Kuwait as an emerging player in the regional synthetic biology landscape.
Browse through Grand View Research's Biotechnology Industry Research Reports.
- The global spine biologics market size was estimated at USD 3.25 billion in 2024 and is projected to grow at a CAGR of 4.9% from 2025 to 2030.
- The global biological data visualization market size was estimated at USD 642.0 million in 2024 and is expected to grow at a CAGR of 8.52% from 2025 to 2030.
Key Synthetic Biology Company Insights
Companies in the synthetic biology industry are focusing on expansion to enhance production and research efforts. Many players are acquiring smaller firms to strengthen their market presence, diversify service offerings, and improve overall capabilities.
Key Synthetic Biology Companies:
The following are the leading companies in the synthetic biology market. These companies collectively hold the largest market share and dictate industry trends.
- Bota Biosciences Inc.
- Codexis, Inc.
- Creative Biogene.
- Creative Enzymes.
- Enbiotix, Inc.
- Illumina, Inc.
- Merck Kgaa (Sigma-Aldrich Co. Llc)
- New England Biolabs
- Eurofins Scientific
- Novozymes
- Pareto Bio, Inc.
- Scarab Genomics, Llc
- Synthego
- Synthetic Genomics Inc.
- Thermo Fisher Scientific, Inc.
View a comprehensive list of companies in the Synthetic Biology Market
Order a free sample PDF of the Synthetic Biology Market Intelligence Study, published by Grand View Research.